TYME-18

N/A

Report date: 2023/03/19 13:26:32

Base Information

Drug NameTYME-18
Drug Alias NameTYME-18
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein biosynthesis inhibitorsFree radicals stimulants
TargetsFree radicals
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSyros Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A